首页>
外国专利>
PHARMACEUTICAL DRUG FORM FOR PERORAL INTRODUCTION TO REDUCE INTER-INDIVIDUAL VARIABILITY, IN PARACETAMOL-CONTAINING COMPOSITIONS IN PATIENT
PHARMACEUTICAL DRUG FORM FOR PERORAL INTRODUCTION TO REDUCE INTER-INDIVIDUAL VARIABILITY, IN PARACETAMOL-CONTAINING COMPOSITIONS IN PATIENT
展开▼
机译:在患者体内含有草胺醇的组合物中,经口服引入以减少个体间差异的药物制剂形式
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, pharmaceutics.;SUBSTANCE: claimed invention relates to application of a pharmaceutical drug form for peroral introduction to reduce inter-individual variability in paracetamol-containing compositions in a diabetic patient with gastric dismotility. The said drug form contains in a form of a granulate: paracetamol in amount 60-80 wt %, calcium carbonate in amount 5-20 wt %, at least, one first binding substance and, at least, one disintegrating substance, as well as, at least, one hydrophilic colloid as an extragranular component.;EFFECT: invention ensures improvement of an active substance absorption in the patient with gastric dismotility.;13 cl, 1 tbl, 3 ex
展开▼
机译:技术领域本发明涉及经口服引入的药物形式在具有胃动力障碍的糖尿病患者中用于减少含对乙酰氨基酚的组合物中个体间差异的用途。所述药物形式包含颗粒形式:对乙酰氨基酚的量为60-80wt%,碳酸钙的量为5-20wt%,至少一种第一结合物质和至少一种崩解物质,以及;至少一种亲水胶体作为颗粒外成分。效果:本发明确保改善患有胃动力不全的患者的活性物质吸收。13 cl,1 tbl,3 ex
展开▼